ECT2-PEPTIDE UND DIESE ENTHALTENDE IMPFSTOFFE

European patent · EP2553096 · Deleted

Register entry

Publication number
EP2553096
Application number
EP11762265
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 30, 2011
Published
Feb 6, 2013
Granted
Nov 22, 2017
Deleted
Oct 23, 2024
Reason
Annual fee unpaid
IPC classes
C12N 15/09 (2006.01)
C07K 7/06 (2006.01)
A61K 39/00 (2006.01)
Priority
US 320577 P 02.04.2010
PCT application
PCT/JP2011/001909 30.03.2011
PCT publication
WO2011/122022 06.10.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 23, 2024

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2024

  2. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  3. Nov 22, 2017

    Granted

    Published in Swissreg on 22.11.2017

Parties

Holder

OncoTherapy Science, Inc.

Oncotherapy Science, Inc.

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Inventor

NAKAMURA, Yusuke

Tokyo 113-8654, JP

TSUNODA, Takuya

Kawasaki-shi Kanagawa 213-0012, JP

OHSAWA, Ryuji

Kawasaki-shi Kanagawa 213-0012, JP

YOSHIMURA, Sachiko

Kawasaki-shi Kanagawa 213-0012, JP

WATANABE, Tomohisa

Kawasaki-shi Kanagawa 213-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.